75
Participants
Start Date
February 14, 2023
Primary Completion Date
December 31, 2023
Study Completion Date
June 30, 2024
INV-001
Patient will be assigned to one of three arms.
RECRUITING
Innovo Therapeutics, Inc., Seoul
Lead Sponsor
Innovo Therapeutics, Inc.
INDUSTRY